---
title: Get four free industry reports and $100 off STAT+
description: Join the STAT+ community today and enjoy unlimited access to award-winning journalism, premium data tools, discounted event tickets, and much more.
image: https://marketing.statnews.com/hubfs/2026ReportPromo_Marketing_Hubspot_MetaImage.png
---

![](https://www.statnews.com/wp-content/uploads/2023/09/Updated-STAT-Plus-logo-30.svg)

Get four free industry reports ($156 value) and $100 off STAT+

Subscribe to STAT+ and unlock critical intelligence for biotech and life sciences executives, including:

All four 2026 STAT Reports on the FDA, NIH, AI in health care, and dementia care

Award-winning investigative journalism and analysis

Exclusive newsletters, premium tools, breaking news alerts, and event discounts

Insert subheading here

Button text

25% OFF

![](https://marketing.statnews.com/hubfs/Landing%20Pages/user.svg)

Individual plan

+4 Reports

$

$299.25

test

[Subscribe](https://www.statnews.com/stat-plus/subscribe/?stat_promo_code=DUmxGQUX&)

Cancel Anytime

Subscriber benefits include

![circle-chevron-down-solid-full](https://marketing.statnews.com/hubfs/circle-chevron-down-solid-full.svg)

![Benefit 1](https://marketing.statnews.com/hubfs/Benefit%201.png "Benefit 1")

Unlimited article access

Unlock access to thousands of must-read stories — 10 years of invaluable investigations, exclusives, and emerging trends.

![image 119](https://marketing.statnews.com/hs-fs/hubfs/image%20119.png?width=424&height=337&name=image%20119.png "image 119")

**Unlimited article access**

Gain unlimited access to thousands of must-read stories — 10 years of invaluable investigations, exclusives, and emerging trends.

Exclusive insights and analysis

Our subscriber-only stories provide expert coverage and behind-the-scenes reporting on industry trends and developments.

![Benefit 2](https://marketing.statnews.com/hubfs/Benefit%202.png "Benefit 2")

![image 118](https://marketing.statnews.com/hs-fs/hubfs/image%20118.png?width=424&height=337&name=image%20118.png "image 118")

**Exclusive insights and analysis**

Our subscriber-only stories provide expert coverage and behind-the-scenes reporting on industry trends and developments.

![Benefit 3](https://marketing.statnews.com/hs-fs/hubfs/Benefit%203.png?width=950&height=768&name=Benefit%203.png "Benefit 3")

Customizable email alerts

Receive breaking news notifications and topic- and author-specific email updates set to you within moments of publication.

![image 119-1](https://marketing.statnews.com/hs-fs/hubfs/image%20119-1.png?width=424&height=337&name=image%20119-1.png "image 119-1")

**Customizable email alerts**

Receive breaking news notifications and topic- and author-specific email updates set to you within moments of publication.

Subscriber-only newsletters

Get exclusive newsletters, like AI Prognosis and Biotech Scorecard, delivered to your inbox daily with in-depth commentary on the latest trends and discoveries.

![Benefit 4](https://marketing.statnews.com/hs-fs/hubfs/Benefit%204.png?width=950&height=768&name=Benefit%204.png "Benefit 4")

![image 119-2](https://marketing.statnews.com/hs-fs/hubfs/image%20119-2.png?width=424&height=337&name=image%20119-2.png "image 119-2")

**Subscriber-only newsletters**

Get exclusive newsletters, like AI Prognosis and Biotech Scorecard, delivered to your inbox daily with in-depth commentary on the latest trends and discoveries.

![Benefit 5](https://marketing.statnews.com/hs-fs/hubfs/Benefit%205.png?width=950&height=768&name=Benefit%205.png "Benefit 5")

Premium data tools

Leverage exclusive trackers on the critical topics of generative AI, obesity drugs, CRISPR, and the FDA's fast-tracked devices.

![image 119-3](https://marketing.statnews.com/hs-fs/hubfs/image%20119-3.png?width=424&height=337&name=image%20119-3.png "image 119-3")

**Premium data tools**

Leverage exclusive trackers on the critical topics of generative AI, obesity drugs, CRISPR, and the FDA fast-tracked devices.

![](https://marketing.statnews.com/hubfs/Landing%20Pages/Icons/Unlocked%20padlock%20icon%20-%20teal%2050.svg)

Unlock stories from behind the paywall

Gain unlimited access to STAT’s archive of articles — nearly 10 years of invaluable research, reference, and emerging trend tracking.

![](https://marketing.statnews.com/hubfs/Landing%20Pages/Icons/Article%20icon%20-%20teal%2050.svg)

Discover the news before anyone else

Stay informed with news and insights from the nation's most trusted and well-connected health care, business, and financial journalists.

![](https://marketing.statnews.com/hubfs/Landing%20Pages/Expanded%20Icons/Team%20icon%20-%20teal%2050.svg)

Meet industry leaders

Unlock discounts and subscriber-only access to STAT Summits and other in-person and virtual events, featuring our award-winning journalism, live.

![](https://marketing.statnews.com/hubfs/Landing%20Pages/Expanded%20Icons/Newsletters%20icon%20-%20teal%2050.svg)

Access subscriber-only newsletters

Exclusive subscriber-only newsletters are delivered to your inbox daily with in-depth commentary on the latest trends and discoveries.

![](https://marketing.statnews.com/hubfs/Landing%20Pages/Expanded%20Icons/Data%20icon%20-%20teal%2050.svg)

And make data-driven decisions

Access premium data tools and industry trackers to identify trends, study competitors, and dive deeper into subjects that matter to you.

Unlock this special offer

Want to access exclusive events, subscriber-only newsletter and alerts, and much more?

[Subscribe Now](https://www.statnews.com/stat-plus/subscribe/?stat_promo_code=DUmxGQUX&)

Questions? We have answers

 What is STAT+?

 STAT+ is STAT’s premium subscription service for in-depth biotech, pharma, policy, and life science coverage and analysis. Our award-winning team covers news on Wall Street, policy developments in Washington, early science breakthroughs and clinical trial results, and health care disruption in Silicon Valley and beyond.

 Can I purchase a Group Subscription for my team?

 If you are interested in discounted access for a smaller group or team, [get started with a group of 2 to 10 members today](https://marketing.statnews.com/groups). If you are interested in access for a group 11+ or larger, [get started with an Enterprise subscription today.](https://www.statnews.com/stat-plus/group-subscriptions/)

 I think I already have access through my institution. How do I find out?

 If you believe you already have access to STAT+ and need help getting started, just email us at [groups@statnews.com](mailto:groups@statnews.com).

![](https://marketing.statnews.com/hubfs/Email%20Template%20Images/black-stat-logo.svg)

[Privacy](https://www.statnews.com/privacy/)     [Terms](https://www.statnews.com/terms-conditions/)     [Do Not Sell My Data With Us](https://www.statnews.com/privacy/)     [©2023 STAT](https://www.statnews.com)

![](https://marketing.statnews.com/hubfs/Email%20Template%20Images/black-stat-logo.svg)

[Privacy](https://www.statnews.com/privacy/)

[Terms](https://www.statnews.com/terms-conditions/)

[Do Not Sell My Data](https://www.statnews.com/privacy/)

©2023 STAT